Page
%P
-
Article
Update on Phase I/II Breast Cancer Prevention Trials
The greatest success in breast cancer prevention has been with two agents, tamoxifen and raloxifene, both of which are approved by the US Food and Drug Administration (FDA) for the risk reduction of invasive b...